Meta-analysis of 7 cohort studies (4,297 patients with Crohn's disease): early immunomodulator therapy was associated with lower risk of intestinal resection than late or no therapy (pooled HR 0.53), most consistently when started within 1-2 years of diagnosis.
Meta-analysisn = 4,297
Yoon et al. Early immunomodulator therapy reduces the risk of intestinal resection in Crohns disease: a systematic review and meta-analysis